Blog
RSS FeedPosted by Michael Wonder on 03 Jun 2023
America will struggle to pay for ultra-expensive gene therapies
1 June 2023 - The drugs may force reform to Medicaid. ...
Posted by Michael Wonder on 17 Oct 2022
Can state prescription drug affordability boards address high cost drug prices?
11 October 2022 - State law makers, like their federal counterparts, are focused on addressing the high and growing cost of ...
Posted by Michael Wonder on 03 Mar 2022
ICER to develop a California state unsupported price increase report funded by the California Health Care Foundation
3 March 2022 - Expanded funding supports the development of two annual “Unsupported Price Increase” reports specific to drugs identified through ...
Posted by Michael Wonder on 14 May 2021
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...
Posted by Michael Wonder on 15 Aug 2020
Many psoriasis patients are paying higher prices than ever at the pharmacy counter
13 August 2020 - Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing financial ...
Posted by Michael Wonder on 01 May 2020
The global imperative to make cancer medications affordable
1 May 2020 - The value of any medication is determined by the magnitude of the clinical benefit (improved survival and ...
Posted by Michael Wonder on 24 Jul 2019
Patients, backed by ‘dark money’ group, get ready to debate Duchenne drug prices. It will not be boring.
24 July 2019 - Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. ...
Posted by Michael Wonder on 07 Apr 2019
Gene therapy was hailed as a revolution. Then came the bill.
7 April 2019 - Cost of new treatments may run into the millions of dollars. ...